IL33 and asthma: Although mast cells are mainly associated with proinflammatory biological effects, the murine chymase mMCP-4 has been shown to have protective properties in experimental asthma, dampening AHR and eosinophilic inflammation, possibly by degrading IL-33, which is a cytokine driving type 2 inflammation [12, 13].